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Abstract. 
 
We previously demonstrated that CALNUC, 
a Ca
 
2
 
1
 
-binding protein with two EF-hands, is the major 
Ca
 
2
 
1
 
-binding protein in the Golgi by 
 
45
 
Ca
 
2
 
1
 
 overlay 
(Lin, P., H. Le-Niculescu, R. Hofmeister, J.M. McCaf-
fery, M. Jin, H. Henneman, T. McQuistan, L. De Vries, 
and M. Farquhar. 1998. 
 
J
 
.
 
 Cell Biol
 
. 141:1515–1527). In 
this study we investigated CALNUC’s properties and 
the Golgi Ca
 
2
 
1
 
 storage pool in vivo. CALNUC was 
found to be a highly abundant Golgi protein (3.8 
 
m
 
g 
CALNUC/mg Golgi protein, 2.5 
 
3
 
 10
 
5
 
 CALNUC mol-
ecules/NRK cell) and to have a single high afﬁnity, low 
capacity Ca
 
2
 
1
 
-binding site (
 
K
 
d 
 
5 
 
6.6 
 
m
 
M, binding ca-
pacity 
 
5 
 
1.1 
 
m
 
mol Ca
 
2
 
1
 
/
 
m
 
mol CALNUC). 
 
45
 
Ca
 
2
 
1
 
 stor-
age was increased by 2.5- and 3-fold, respectively, in 
HeLa cells transiently overexpressing CALNUC-GFP 
and in EcR-CHO cells stably overexpressing CAL-
NUC. Deletion of the ﬁrst EF-hand 
 
a
 
 helix from CAL-
NUC completely abolished its Ca
 
2
 
1
 
-binding capability. 
CALNUC was correctly targeted to the Golgi in trans-
fected cells as it colocalized and cosedimented with the 
Golgi marker, 
 
a
 
-mannosidase II (Man II). Approxi-
mately 70% of the 
 
45
 
Ca
 
2
 
1
 
 taken up by HeLa and CHO 
cells overexpressing CALNUC was released by treat-
ment with thapsigargin, a sarcoplasmic/endoplasmic 
reticulum calcium ATPase (SERCA) (Ca
 
2
 
1
 
 pump) 
blocker. Stimulation of transfected cells with the ago-
nist ATP or IP
 
3
 
 alone (permeabilized cells) also re-
sulted in a signiﬁcant increase in Ca
 
2
 
1
 
 release from 
Golgi stores. By immunoﬂuorescence, the IP
 
3
 
 receptor 
type 1 (IP
 
3
 
R-1) was distributed over the endoplasmic 
reticulum and codistributed with CALNUC in the 
Golgi. These results provide direct evidence that
CALNUC binds Ca
 
2
 
1
 
 in vivo and together with 
SERCA and IP
 
3
 
R is involved in establishment of the 
agonist-mobilizable Golgi Ca
 
2
 
1
 
 store.
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EF-hand • IP
 
3
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T
 
HE
 
 Golgi complex is involved in posttranslational
modification of newly synthesized proteins and
serves as the main sorting station for protein and
vesicular traffic (Farquhar and Hauri, 1997; Farquhar
and Palade, 1998). Calcium is well known to be essential
for cell signaling (Tsien and Tsien, 1990; Meldolesi and
Pozzan, 1998) but also for cell processes such as protein
processing and membrane traffic to and through the Golgi
(Davidson et al., 1988; Ivessa et al., 1995; Duncan and Bur-
goyne, 1996). Recently the Golgi has been identified as a
Ca
 
2
 
1
 
-enriched compartment using ion microscopy and
electron energy loss spectroscopy-electron spectroscopic
imaging (EELS-ESI) (Chandra et al., 1991; Grohovaz et al.,
1996; Pezzati et al., 1997). Ca
 
2
 
1
 
 can be released from the
Golgi by the Ca
 
2
 
1
 
 ionophore A23187 (Chandra et al.,
1991), the Ca
 
2
 
1
 
 channel blocker La
 
3
 
1
 
 (Zha and Morrison,
1995), and histamine, an agonist known to be coupled to
IP
 
3
 
 generation (Pinton et al., 1998). How the high level of
Ca
 
2
 
1
 
 in the Golgi is maintained is unknown at present.
The ER Ca
 
2
 
1
 
 pool (or Ca
 
2
 
1
 
 store) has been studied
more extensively and is known to be maintained by or-
ganelle-associated Ca
 
2
 
1
 
 ATPase (Ca
 
2
 
1
 
 pumps) and lume-
nal Ca
 
2
 
1
 
-binding proteins of which there are many (Bas-
tianutto et al., 1995; Meldolesi and Pozzan, 1998). There is
also evidence for the existence of Ca
 
2
 
1
 
 pumps on the
Golgi based on ATP-dependent Ca
 
2
 
1
 
 uptake into mam-
malian (Baumrucker and Keenan, 1975; Hodson, 1978;
Neville et al., 1981; Virk et al., 1985) and yeast (Sorin et al.,
1997) Golgi fractions. Both sarcoplasmic/ER calcium ATP-
 
ase (SERCA)
 
1
 
 and plasma membrane calcium ATPase
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en route to the plasma membrane are essential for Ca
 
2
 
1
 
uptake into isolated Golgi fractions (Taylor et al., 1997).
However, information on Golgi calcium-binding proteins
is still limited and the detailed mechanisms of Ca
 
2
 
1
 
 up-
take, storage, and release from the Golgi apparatus re-
main to be elucidated. Previously, we demonstrated that
CALNUC (nucleobindin) (Miura et al., 1992; Wendel et al.,
1995), a Golgi resident protein that faces the Golgi lumen,
is the major Ca
 
2
 
1
 
-binding protein in the Golgi based on
 
45
 
Ca
 
2
 
1
 
 overlay (Lin et al., 1998).
In this study we have investigated the role of CALNUC
in establishing the Golgi Ca
 
2
 
1
 
 pool in vivo by examining
the effects of overexpression of CALNUC on Ca
 
2
 
1
 
 up-
take. We provide direct evidence that CALNUC possesses
high affinity/low capacity Ca
 
2
 
1
 
 binding properties and
binds Ca
 
2
 
1
 
 in the Golgi in vivo. The finding that the ma-
jority of the Ca
 
2
 
1
 
 sequestered by overexpressed CAL-
NUC is released by thapsigargin (Tg), ATP, and IP
 
3
 
 pro-
vides additional in vivo evidence for the existence of
SERCA and inositol 1, 4, 5 trisphosphate receptor (IP
 
3
 
R)
on the Golgi. CALNUC together with SERCA and IP
 
3
 
R
on Golgi membranes constitute a cellular Ca
 
2
 
1
 
 pool in the
Golgi which may have distinct functions.
 
Materials and Methods
 
Materials
 
Polyclonal antibody (F-5059) against full-length, recombinant CALNUC
was generated and affinity purified as previously described (Lin et al.,
1998). Polyclonal anti–
 
a
 
-mannosidase II (Man II) was prepared as de-
scribed (Velasco et al., 1993). Monoclonal anti–Man II (53FC3) and poly-
clonal antibody against denatured Man II were gifts from Drs. B. Burke
(University of Alberta, Alberta, Canada) and K. Moremen (University of
Georgia, Athens, GA), respectively. Monoclonal anti–mouse IP
 
3
 
R-1
(18A10) was kindly provided by Drs. A. Miyawaki and K. Mikoshiba
(University of Tokyo, Tokyo, Japan) (Furuichi et al., 1989). Polyclonal an-
tibody against calnexin was a gift from Dr. J.J.M. Bergeron (McGill Uni-
versity, Montreal, Canada). Cross-absorbed Texas red–conjugated don-
key anti–rabbit F(ab
 
9
 
)
 
2
 
 was obtained from Jackson ImmunoResearch
Laboratories, and affinity-purified goat anti–rabbit IgG (H
 
1
 
L) conju-
gated to HRP was from Bio-Rad. 
 
45
 
CaCl
 
2
 
 was obtained from NEN Life
Science Products. Supersignal chemiluminescent reagent was purchased
from Pierce. All chemical reagents were from Sigma Chemical Co. except
as indicated.
 
Preparation and Purification of His6-CALNUC
 
Full-length CALNUC cDNA was amplified by PCR using 5
 
9
 
-CGCGCG-
GCAGCCATATGCCTACCTCTGTG-3
 
9
 
 and 5
 
9
 
-CGGAATTCGGAT-
CCTTATAAATGCTGAGAATC-3
 
9
 
 as primers. PCR was carried out us-
ing 100 pmol of each primer, 2 ng CALNUC cDNA, 200 
 
m
 
M dNTP, 2.5 U
PFU polymerase (Stratagene), and PCR reaction buffer in a total volume
of 50 
 
m
 
l. PCR products were purified using a QIAquick PCR Purification
kit (Qiagen) and subcloned into the pET-28a(
 
1
 
) vector (Novagen) at
BamHI/NdeI restriction sites, followed by transformation into 
 
Escheri-
chia coli
 
 BL21(DE3). Expression of CALNUC protein was induced with
1 mM isopropyl 
 
b
 
-
 
D
 
-thiogalactoside (IPTG) (Pharmacia Biotech) at 18
 
8
 
C
for 4 h at a bacterial density of OD
 
600
 
 
 
$
 
 1.0.
To purify His6-CALNUC protein, transformed
 
 E
 
.
 
 coli
 
 were suspended
in binding buffer containing 20 mM sodium phosphate and 500 mM NaCl
(pH 7.5), and sonicated using a Microson Ultrasonic Cell Disrupter (Heat
Systems). Lysates were incubated with Ni-NTA agarose (Qiagen), washed
with 20 mM sodium phosphate, 500 mM NaCl at decreasing pH (8.0, 6.0,
and 5.3), and bound proteins were sequentially eluted with an imidazole
step gradient (10 mM to 1 M). Fractions containing a single band of puri-
fied CALNUC detected by silver staining were pooled and dialyzed
against TBS containing 150 mM NaCl and 10 mM Tris-HCl (pH 7.4) at
4
 
8
 
C, and subsequently concentrated using an Ultrafree-15 (Biomax-50K)
 
filter (Millipore). Highly purified His6-CALNUC [0.6 mg/liter of trans-
formed BL21(DE3)] was obtained.
 
Ca
 
2
 
1
 
-binding Analysis
 
Equilibrium dialysis was performed essentially as previously published
(MacLennan and Wong, 1971; Baksh and Michalak, 1991). Ca
 
2
 
1
 
-free solu-
tion was prepared by treatment of deionized water with a UniPure I Wa-
ter Purification System (Solution Consultants) and Chelex 100 ion ex-
change resin (Bio-Rad) (Thielens et al., 1990). Equilibrium dialysis was
performed using a Dialysis System (GIBCO BRL). 0.25 mg Ca
 
2
 
1
 
-depleted
CALNUC (Thielens et al., 1990) was incubated with 0.35 
 
m
 
Ci/ml 
 
45
 
CaCl
 
2
 
and different concentrations of cold Ca
 
2
 
1
 
 at 4
 
8
 
C for 16 h, followed by as-
sessment of radioactivity using a LS 6000IC Liquid Scintillation System
(Beckman Instruments) in EcoLume liquid scintillation cocktail (ICN).
Scatchard analysis was performed using CA Cricket Graph III software
(Computer Associates International).
 
Primary Structure Comparison
 
Amino acid sequences of CALNUC, Cab45 (Scherer et al., 1996), and
calmodulin (CaM) were obtained through Entrez on the National Center
for Biotechnology Information’s (NCBI) World Wide Web home page.
Alignment of EF-hand motifs was performed using MacVector 6.0 soft-
ware (Oxford Molecular Groups-IBI).
 
Cell Culture
 
HeLa cells were maintained in DME high glucose medium (Irvine Scien-
tific) supplemented with 10% FCS (Life Technologies Inc.). Cells were
used as 80% confluent monolayers for transfection. Transfected EcR-
CHO cells were cultured in Ham’s F12 medium (CORE Cell Culture Fa-
cility, University of California, San Diego, CA) with 10% FCS (Life Tech-
nologies), 250 
 
m
 
g/ml Zeocin (Invitrogen), and 750 
 
m
 
g/ml G418 sulfate
(Calbiochem). All media contained 100 U/ml of penicillin G and 100 
 
m
 
g/
ml of streptomycin sulfate. NRK cells were cultured as previously de-
scribed (Lin et al., 1998).
 
Transient Overexpression of CALNUC-Green 
Fluorescent Protein (GFP) or Truncated
CALNUC-GFP in HeLa Cells
 
CALNUC cDNA was amplified by PCR with the primers 5
 
9
 
-CGCG-
GATCCATGCCTACCTCTGTG-3
 
9
 
 and 5
 
9
 
-CCATGCCATGGCTAAA-
TGCTGAGAATCC-3
 
9
 
. GFP cDNA was also amplified by PCR with the
primers 5
 
9
 
-TCATGCCATGGTGAGCAAGGG-3
 
9
 
 and 5
 
9
 
-ATAGTTTA-
GCGGCCGCTTACTTGTACAGCTC-3
 
9. PCR products were purified
and digested, respectively, with BamHI, NcoI, and NotI (New England
Biolabs). CALNUC and GFP cDNA were subcloned into the pcDNA3
vector (Invitrogen) by three-fragment ligation to obtain a CALNUC-
GFP/pcDNA3 construct with GFP ligated to the 39 (COOH terminus) of
CALNUC.
CALNUC(DEF-1), in which the a helix (Asp227–Leu239) of the first EF-
hand (EF-1) domain (see Fig. 1) was deleted, was obtained by PCR with
the primers 59-CGCGGATCCATGCCTACCTCTGTG-39/59-CCCAA-
GCTTATGCAGTATGAAGAA-39, and 59-CCCAAGCTTGAAGCT-
CTGTTTACC-39/59-CCATGCCATGGCTAAATGCTGAGAATCC-39.
CALNUC(DEFs-1,2), in which both EF-1 and EF-2 domains (Asp227–
Phe291) (see Fig. 1) were deleted, was prepared with primers of 59-CGCG-
GATCCATGCCTACCTCTGTG-39/59-CCCAAGCTTATGCAGTAT-
GAAGAA-39, and 59-CCCAAGCTTCTGGCATCCACACAG-39/59-CCA-
TGCCATGGCTAAATGCTGAGAATCC-39. CALNUC mutants and
the GFP tag were subcloned into the pcDNA3 vector by four-fragment li-
gation with HindIII and NcoI as internal restriction linker sites. Fidelity of
the constructs was verified by automated DNA sequencing (CFAR, Uni-
versity of California, San Diego, CA). cDNA constructs were transformed
into  E. coli DH5a, followed by extraction and purification using
QIAGEN Plasmid Midi/Mega Kits (Qiagen) and UltraPure CsCl (optical
grade) (GIBCO BRL).
To express wild-type or truncated CALNUC-GFP in HeLa cells, 1 mg
purified DNA was transfected into HeLa cells (33-mm dish, 80% conflu-
ence) using 6 mg lipofectamine (GIBCO BRL). Transfected cells were
grown in serum and antibiotic-free high glucose DME medium for 5 h fol-
lowed by replacement with regular culture medium.Lin et al. CALNUC Binds Ca21 in the Golgi 281
Establishment of a Stable HeLa Cell Line 
Overexpressing GFP Using Flow Cytometry
GFP cDNA amplified by PCR with the primers 59-TCGCGGATCCA-
TGGTGAGCAAGGG-39 and 59-ATAGTTTAGCGGCCGCTTACTT-
GTACAGCTC-39 was subcloned into the pcDNA3 vector at BamHI/
NotI restriction sites, followed by transfection into HeLa cells as de-
scribed above and G418 selection (0.75 mg/ml) for 4 d. Cells expressing
GFP were sorted by flow cytometry (Ex/Em: 488/530 6 15) (FACStar
Plus®; Becton Dickinson) in the UCSD Flow Cytometry Core Facility.
The top 0.12% of the positive cells was collected and maintained in media
containing 0.75 mg/ml G418 until confluent. Selection by sorting was re-
peated three times until 100% of the cells (HeLa-GFP, GPH-1216) ex-
pressed GFP (data not shown).
Establishment of Stable Cell Lines Overexpressing 
CALNUC in the Ecdysone-inducible Mammalian 
Expression System
CALNUC cDNA was amplified by PCR and subcloned into the pIND
vector (Invitrogen) at BamHI/NotI restriction sites. EcR-CHO cells (In-
vitrogen) stably expressing the ecdysone receptor (RxR and VgEcR) were
transfected with CALNUC/pIND plasmid DNA using lipofectamine as
described above followed by selection for G418 resistance (0.4 mg/ml) for
18 d. Cells were split into 96-well plates by serial dilution, 0.5 cells/well,
and subsequently reselected with G418 (0.75 mg/ml). Four clones overex-
pressing CALNUC after induction with muristerone A (Invitrogen) were
obtained; one of these, EcR-CHO-CALNUC-1 (CPC-22A), was used for
these experiments.
Immunocytochemistry
CALNUC-GFP was directly visualized using a Zeiss Axiophot micro-
scope and an FITC-filter (Ex/Em: 485/510). For immunofluorescence,
cells on coverslips were fixed with 2% paraformaldehyde (50 min), per-
meabilized with 0.1% Triton X-100 (10 min), and incubated with affinity-
purified anti-CALNUC IgG (6 mg/ml), anti–Man II serum (1:300), or
anticalnexin serum (1:100) as previously described (Lin et al., 1998).
Detection was with Texas red– or FITC-conjugated donkey anti–rabbit
F(ab9)2. In some cases cells were doubly stained for CALNUC and either
a mouse mAb against Man II (40 mg/ml) or the IP3R-1 (1.25 mg/ml) and
appropriate secondary antibodies. Specimens were examined with either a
Zeiss Axiophot equipped for epifluorescence or a Bio-Rad confocal mi-
croscopy (MRC 1024) equipped with Lasersharp 3.1 software (Bio-Rad)
and a krypton-argon laser. Images were processed with Scion Image and
Adobe Photoshop (Adobe Systems) software.
Subcellular Fractionation
Sucrose gradient flotation of Golgi fractions was carried out using a proto-
col similar to those previously published (Fries and Rothman, 1980;
Brown and Farquhar, 1987) with minor modifications. In brief, microso-
mal membranes were resuspended in 1.5 ml 55% sucrose (wt/wt), loaded
at the bottom of a sucrose step gradient consisting of 40, 35, 30, 25, and
20% (wt/wt in 1 mM Tris-HCl, pH 7.5), and centrifuged at 85,500 g for 16 h
at 48C using a SW-40Ti rotor (Beckman). 20 fractions were collected from
the bottom, followed by SDS-PAGE and immunoblotting for calnexin (an
ER marker), Man II (a Golgi marker), and CALNUC.
Rat liver Golgi fractions, membrane (100,000 g pellet) and cytosolic
(100,000 g supernatant) fractions were prepared from postnuclear super-
natants of transfected HeLa or EcR-CHO-CALNUC cells as previously
described (Saucan and Palade, 1994; Jin et al., 1996; Lin et al., 1998).
Immunoblotting and SDS-PAGE
Proteins were separated by 5 or 10% SDS-PAGE, transferred to PVDF
membranes, and immunoblotted with affinity-purified anti-CALNUC
IgG, anticalnexin, and anti–Man II serum followed by HRP-conjugated
anti–rabbit IgG and detection by ECL (Lin et al., 1998).
45Ca21 Equilibrium Uptake and Release
The procedures followed were those reported previously (Bastianutto et al.,
1995). Cells (2 3 106) transfected with CALNUC-GFP or GFP alone were
incubated with 45Ca21 (2 mCi/ml) for 48 h to reach 45Ca21 equilibrium after
which they were washed three times in Krebs-Ringer-Hepes (KRH)
buffer (125 mM NaCl, 5 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2 mM
CaCl2, 6 mM glucose, and 25 mM Hepes, pH 7.4) and five times with PBS.
45Ca21 was extracted with 0.1 N HCl (30 min at room temperature) and ra-
dioactivity assessed as described above. To examine 45Ca21 release after
stimulation, washed cells were resuspended in KRH supplemented with
3 mM EGTA and stimulated at room temperature with 100 mM ATP or
sequentially stimulated with 0.1 mM Tg, 2 mM ionomycin, and 2 mM mo-
nensin, 5 min each. Equal aliquots (106 cells) were collected after each
stimulation, followed by centrifugation at 14,000 rpm (30 s) and quantifi-
cation of 45Ca21 in the supernatant.
Ca21 Imaging
Noninduced or induced EcR-CHO-CALNUC cells were loaded with 1
mM Fura-2 AM (Molecular Probes Inc.) in Ham’s F12 medium/0.5% FCS
at 228C for 1 h, washed with Ca21-free HBSS (Irvine Scientific) followed
by addition of 100 mM ATP. Ca21 release was monitored by Ca21 imaging
performed on a Zeiss Axiovert microscope equipped with a cooled
charge-coupled CCD camera (Photometrics) and MetaFluor software
(Universal Imaging). Dual-excitation ratio imaging was obtained using
two excitation filters (340DF20 and 380DF20) (Omega Optical and
Chroma Technology) mounted on a filter wheel (Lambda 10-2; Sutter In-
struments), a 420DRLP dichroic mirror, and a 510DF80 emission filter.
Assessment and Mobilization of Stored Ca21 by IP3 in 
Permeabilized Cells
The procedures used were basically similar to those published (Berridge
et al., 1984; De Smedt et al., 1997) with minor modifications. To examine
equilibrium 45Ca21 uptake, EcR-CHO-CALNUC cells induced with 5 mM
ponasterone A for 24 h in a 6-well culture plate (106 cells/well) were per-
meabilized at 208C for 4 min with saponin (50 mg/ml) in loading buffer
(140 mM KCl, 20 mM NaCl, 2 mM MgCl2, 2 mM ATP, 0.1 mM EGTA,
20 mM Pipes, pH 6.80), and 0.13 mM free Ca21 calculated for conditions of
pH 6.80, at 208C (Tsien and Pozzan, 1989). Cells were washed four times
with loading buffer and subsequently loaded with 45Ca21 (10 mCi/ml) for
various times (10–60 min). They were then rinsed five times with loading
buffer (30 s), stored 45Ca21 was extracted with 1 ml 0.1 N HCl for 30 min,
and 0.5-ml aliquots were counted.
To investigate 45Ca21 mobilization by IP3, induced and permeabilized
EcR-CHO-CALNUC cells were loaded with 10 mCi/ml of 45Ca21 as above
for 45 min. After washing (five times over 1–1.5 min), cells were chal-
lenged with 10 mM IP3 (D-myo-inositol 1,4,5-trisphosphate potassium salt)
in loading buffer, 1 ml/well. Solutions were collected at 2-min intervals, re-
placed with loading buffer containing IP3, and counted.
Results
Quantification of Endogenous CALNUC in Rat Liver 
Golgi Fractions and NRK Cells
To quantify endogenous CALNUC in rat liver Golgi frac-
tions, a linear standard curve was obtained for purified
His6-CALNUC (1.3–40 ng) by immunoblotting and densi-
tometric analysis (data not shown). Endogenous CAL-
NUC was found to be present in pooled Golgi light and
heavy fractions from rat liver (Saucan and Palade, 1994;
Jin et al., 1996) at a concentration of 3.8 mg/mg Golgi pro-
tein, i.e., z0.4% of the total Golgi protein (includes both
Golgi resident proteins and cargo in transit through the
Golgi). NRK cells were found to have 0.02 mg CALNUC/
106 cells, or 2.5 3 105 CALNUC molecules/NRK cell.
CALNUC EF-1 Is an Ideal EF-Hand Ca21-binding 
Motif and Constitutes a High Affinity, Low Capacity 
Ca21-binding Site
An ideal EF-hand Ca21-binding motif has an a helix–
loop–a helix structure in which oxygen ligands (O) pro-
vided by carboxy side chains of Asp (D)/Glu (E), carbonylThe Journal of Cell Biology, Volume 145, 1999 282
groups (C9O) of the peptide main chain and H2O consti-
tute the Ca21-binding site, and a hydrophobic amino acid
(f) and a Gly (G) are essential for Ca21 binding (Kret-
singer, 1987; Branden and Tooze, 1991). CALNUC and
Cab45 (Scherer et al., 1996) are the only EF-hand, Ca21-
binding proteins identified so far in the Golgi. Since their
Ca21-binding constants are not yet known, in order to pre-
dict and compare the Ca21-binding properties of these two
proteins, we compared the EF-hand primary structures of
CALNUC (two EF-hands), Cab45 (six EF-hands), and
CaM (four EF-hands). Cab45’s and CaM’s EF-hand motifs
are similar (Scherer et al., 1996), and CaM’s Ca21-binding
properties have been well characterized.
As shown in Fig. 1 A, CALNUC EF-1, Cab45 EF-2 and
-5, and all four CaM EF-hand structures constitute ideal
EF-hand motifs. CALNUC EF-1 and EF-2 are strikingly
similar to CaM EF-4 and Cab45 EF-5, but CALNUC EF-2
has an Arg (R) instead of Gly at residue 6 (Fig. 1 B). This
suggests that CALNUC has only a single ideal EF-hand
motif, EF-1.
To investigate the binding affinity of CALNUC for
Ca21, we performed equilibrium dialysis. Purified recom-
binant His6-CALNUC was used based on a report that re-
combinant calreticulin (CRT) was comparable to native
CRT in its Ca21-binding capability (Baksh and Michalak,
1991). Scatchard analysis of the binding curve (Fig. 1 C)
indicates that CALNUC binds Ca21 with a high affinity
binding constant (Kd 5 6.6 mM) and a low capacity, z1.1
mmol Ca21/mmol protein, suggesting only one high affin-
ity, low capacity Ca21-binding site on CALNUC.
Overexpressed CALNUC Colocalizes with the Golgi 
Marker Man II
To further investigate Ca21 binding to CALNUC in vivo,
we expressed CALNUC-GFP by transient transfection in
HeLa cells and generated an inducible cell line, EcR-
CHO-CALNUC, stably expressing CALNUC. By immu-
noblotting, CALNUC-GFP (90 kD) was detected in tran-
siently transfected HeLa cells but not in nontransfected
cells (Fig. 2 A). The majority of the CALNUC (z85%)
was associated with membranes (100,000 g pellet) and the
remainder (15%) was present in the cytosolic fraction
(100,000 g supernatant). Three additional bands (Fig. 2
A), also visualized after in vitro translation (data not
shown), were also seen. They could be products of protein
degradation or mistranslated CALNUC retained in the cy-
tosol. By immunofluorescence the distribution of CAL-
NUC-GFP overlapped with that of the Golgi marker Man
II (Fig. 3 A), indicating that the majority of the CALNUC-
GFP is correctly targeted to the Golgi.
In EcR-CHO-CALNUC cells induced with muristerone
A or ponasterone A (0.1–10 mM) for 24 h, we found a lin-
ear increase in the expression of CALNUC with increas-
ing amounts of added hormone (Fig. 2 B). The ratio of
CALNUC in membrane versus cytosolic fractions was
similar to that of CALNUC-GFP in HeLa cells (data not
shown). By immunofluorescence the distribution of CAL-
NUC again overlapped with that of Man II in the Golgi re-
gion (Fig. 3 C) in EcR-CHO-CALNUC cells induced with
10 mM muristerone A for 24 h, and was distinct from that
of the ER marker, calnexin (Fig. 3 B).
Cosedimentation of Overexpressed CALNUC and Man 
II in Sucrose Gradients
Next we analyzed the distribution of CALNUC in induced
EcR-CHO-CALNUC cells using an established procedure
for flotation of Golgi membranes and their separation
Figure 1. CALNUC EF-1 is an ideal EF-hand Ca21-binding mo-
tif. (A) Alignment of the EF-hand loop domains constituting the
key Ca21-binding sites in CALNUC, Cab45, and CaM. Consen-
sus amino acids characteristic of ideal EF-hand motifs with oxy-
gen atom–containing side chains (O), a hydrophobic amino acid
(F), and Gly (G) are boxed. Amino acid numbering correspond-
ing to each EF-hand is as follows: CALNUC (220–246 and 272–
298, Z36277), Cab45 (103–129, 142–168, 201–227, 238–264, 283–
309, 319–345, U45977), and CaM (14–40, 50–76, 87–113, 124–150,
M26151). Numbers in parentheses refer to the amino acid posi-
tions and the GenBank accession numbers, respectively. (B) Pri-
mary structure of EF-hands in CALNUC, Cab45, and CaM. Se-
quence comparison shows that CALNUC EF-1 and EF-2 have
the highest similarity to Cab45 EF-5 and CaM EF-4, except that
CALNUC EF-2 has an Arg (R) instead of a Gly at residue 6 of
the loop region. (C) Binding of Ca21 to CALNUC is high affinity
and low capacity. CALNUC binding to Ca21 was examined by
equilibrium dialysis. Scatchard analysis reveals the existence of
one high affinity (Kd 5 6.6 mM)/low capacity (z1.1 mmol Ca21/
mmol of protein) Ca21-binding site on CALNUC. Results repre-
sent the average of values from six separate experiments per-
formed in triplicate.Lin et al. CALNUC Binds Ca21 in the Golgi 283
from ER membranes. As shown in Fig. 4, we found that
CALNUC and Man II cosedimented and peaked in frac-
tions 12–15 with sucrose densities similar to those previ-
ously reported (1.10–1.14 g/ml) (Dunphy and Rothman,
1983; Brown and Farquhar, 1987) for CHO cells. By con-
trast, the ER marker, calnexin, peaked in denser fractions
7–11 (1.16–1.19 g/ml). These results together with the
immunofluorescence findings demonstrate that overex-
pressed CALNUC is found in the Golgi and is consistent
with our previous conclusion (Lin et al., 1998) that overex-
pression does not lead to mistargeting of CALNUC.
Overexpression of CALNUC-GFP or CALNUC in the 
Golgi Increases 45Ca21 Uptake
To assess whether overexpressed CALNUC-GFP binds
Ca21 in the Golgi, we carried out in vivo equilibrium Ca21
uptake. The 45Ca21 loading time was z48 h, the time
shown previously to be long enough to reach 45Ca21 equi-
librium in cultured cells (Mery et al., 1996). 45Ca21 uptake
by HeLa cells transiently overexpressing CALNUC-GFP
was 2.5-fold that of nontransfected HeLa cells or those sta-
bly expressing GFP alone (Fig. 5 A). Similarly, there was a
threefold increase in 45Ca21 taken up by induced (5 mM
muristerone A for 48 h) versus noninduced EcR-CHO-
CALNUC cells (Fig. 5 B). These results demonstrate that
Golgi-associated CALNUC binds Ca21 in vivo and most
likely is responsible for sequestering Ca21 in the Golgi
lumen.
To investigate whether EF-1 is indeed the sole Ca21-
binding motif in CALNUC, we examined Ca21 binding in
HeLa cells transiently transfected with truncated CAL-
NUC-GFP mutants. When the a helix of EF-1 (Asp227–
Leu239) or both EF-1 and EF-2 (Asp227–Phe291) were de-
leted from CALNUC, its Ca21-binding capability was
completely abolished (Fig. 5 A). Mistargeting could be
ruled out since the majority of the mutant CALNUC-GFP
was detected in the Golgi region by fluorescence. The re-
sults obtained from this in vivo Ca21-binding analysis pro-
vide direct evidence that CALNUC binds Ca21 in the
Golgi, and EF-1 constitutes the sole Ca21-binding site on
CALNUC. The latter is in agreement with the data shown
in Fig. 1.
Release of Sequestered 45Ca21 by the SERCA
Inhibitor, Tg
To further investigate the characteristics of the Golgi Ca21
pool, we performed experiments similar to those done pre-
viously to characterize the ER Ca21 pool in cells overex-
pressing CRT (Bastianutto et al., 1995; Mery et al., 1996).
When HeLa cells transiently overexpressing CALNUC-
GFP or EcR-CHO-CALNUC cells stably expressing
CALNUC were treated with the SERCA inhibitor Tg
(Thastrup et al., 1990), z73% and 70%, respectively, of
the 45Ca21 was released (Fig. 6), suggesting the existence
of SERCA on Golgi membranes. Since some Tg-insensi-
tive organelles are capable of retaining Ca21 after Tg
treatment, we subsequently treated cells with the Ca21
ionophore ionomycin to release the remaining stored
45Ca21. Nearly all the remaining 45Ca21 (z20–25%) was
released by ionomycin (Fig. 6). In view of the fact that ion-
omycin is inactivated in acidic compartments such as
secretory granules and endosomes, we further treated cells
with monensin, a carboxylic sodium proton ionophore
which releases Ca21 from acidic compartments (Bas-
tianutto et al., 1995; Mery et al., 1996) and found ,5% of
the 45Ca21 was released. Cells overexpressing CALNUC-
GFP or induced EcR-CHO-CALNUC cells released twice
as much 45Ca21 as nontransfected HeLa cells, HeLa cells
stably expressing GFP alone, or noninduced EcR-CHO-
CALNUC cells. The fact that the majority of the 45Ca21
taken up by CALNUC was released by Tg suggests that
both CALNUC and SERCA play a key role in sequester-
ing 45Ca21 in the Golgi, a conclusion in agreement with the
recent description of SERCA associated with isolated
Golgi fractions (Taylor et al., 1997).
Release of Sequestered Ca21 from the Golgi by 
Extracellular ATP
We next examined whether or not Ca21 sequestered in the
Golgi is released after agonist challenge. Extracellular
Figure 2. Biochemical analysis of CALNUC expression in trans-
fected cells. (A) HeLa cells transiently transfected with CAL-
NUC-GFP. By immunoblotting (50 mg protein), z85% of the
CALNUC-GFP (90 kD) is associated with the membrane pellet
(M), and the remaining 15% is found in the cytosolic fraction
(Cyt). No signal was detected in nontransfected HeLa cells
(N.T.) when the same amount of protein was examined. HeLa
cells transfected with CALNUC-GFP cDNA (48 h) were homog-
enized and membrane (100,000 g pellet) and cytosolic (100,000 g
supernatant) fractions were prepared from the postnuclear su-
pernatant. The pellet was resuspended in the same volume as the
supernatant, and equal volumes of the membrane and cytosolic
fractions were analyzed by SDS-PAGE and immunoblotted with
affinity-purified anti-CALNUC IgG. (B) Expression of CAL-
NUC in inducible, stably transfected EcR-CHO-CALNUC cells.
By immunoblotting increasing amounts of CALNUC were de-
tected in cell lysates (80 mg) after induction with increasing
amounts (0.5–10 mM) of muristerone A. Cells stably transfected
with CALNUC were lysed in 1% Triton X-100. Lysates (80 mg)
were separated by SDS-PAGE and immunoblotted with affinity-
purified anti-CALNUC IgG.The Journal of Cell Biology, Volume 145, 1999 284
Figure 3. (A–C) Overexpressed CALNUC is correctly targeted to the Golgi. (A) HeLa cells transiently expressing CALNUC-GFP.
CALNUC-GFP is concentrated in the Golgi region where it partially overlaps with the Golgi marker Man II. Cells were fixed in
paraformaldehyde, permeabilized, and incubated with anti–Man II serum followed by Texas red–conjugated donkey anti–rabbitLin et al. CALNUC Binds Ca21 in the Golgi 285
ATP is known to activate phospholipase C (PLC) (Brown
et al., 1991) via binding to G protein–coupled nucleotide
receptors on the cell surface (O’Connor, 1992). Activated
PLC promotes production of IP3 which binds to IP3R on
the ER and triggers Ca21 mobilization. To investigate
whether Ca21 sequestered by overexpressed CALNUC in
the Golgi could be released by agonist, we examined Ca21
release in EcR-CHO-CALNUC cells by Ca21 imaging af-
ter ATP challenge. The results (Fig. 7 A) demonstrated
that the ratio, 340:380, was doubled in cells induced with
2.5 mM ponasterone A for 24 h compared with noninduced
cells, suggesting that more Ca21 was released from in-
duced cells. Similar results were also obtained when in-
duced EcR-CHO-CALNUC cells were loaded with 45Ca21
(Fig. 7 B). These results obtained by two different meth-
ods suggest that the Golgi Ca21 store is sensitive to IP3
generated after ATP binding.
Release of 45Ca21 Sequestered in the Golgi by IP3
To obtain direct evidence that IP3 is able to release Ca21
from the Golgi, 45Ca21 uptake and release studies were
performed on permeabilized EcR-CHO-CALNUC cells.
Fig. 8 A reveals that 45Ca21 is rapidly taken up by both in-
duced and noninduced permeabilized cells, but approxi-
mately twice the amount of 45Ca21 was sequestered by
cells overexpressing CALNUC. Steady state was achieved
45 min after loading, which was slower than reported for
Swiss 3T3 cells (20 min) (Berridge et al., 1984). 45Ca21 re-
lease was then stimulated by addition of IP3 (Fig. 8 B). The
ratio of 45Ca21 released from induced versus noninduced
cells was z2:1. These results support the previous report
of Pinton and colleagues (1998) suggesting that both Golgi
membranes and ER membranes bear IP3R.
Localization of the IP3 Receptor on the Golgi and ER
by Immunofluorescence
In view of the functional evidence for the existence of
IP3R on the Golgi, we carried out immunofluorescence
studies on NRK cells and induced EcR-CHO-CALNUC
cells using a mAb that recognizes IP3R-1. IP3R-1 was
Figure 4. CALNUC cosediments with Man II in
sucrose gradients. Total microsomes prepared
from induced EcR-CHO-CALNUC cells were
subjected to sucrose gradient flotation (85,500 g
for 16 h) as described in Materials and Methods.
20 fractions were collected from the bottom, fol-
lowed by 5 or 10% SDS-PAGE and immuno-
blotting analysis. CALNUC peaked in fractions
12–15 where it cosedimented with the Golgi
marker Man II, whereas the ER marker calnexin
peaked in denser fractions 7–11.
F(ab9)2 as described in Materials and Methods. (B) Induced or noninduced EcR-CHO-CALNUC cells. Overexpressed CALNUC is
concentrated in the Golgi region in the induced cells in a pattern distinct from that of the ER marker, calnexin. Virtually no signal is de-
tected in noninduced cells. Induced (muristerone A, 10 mM for 24 h) or noninduced cells were labeled with affinity-purified anti-CAL-
NUC or anticalnexin serum and processed as in A. (C) Double labeling of induced EcR-CHO-CALNUC cells with anti-CALNUC IgG
and anti–Man II mAb. The distribution of overexpressed CALNUC overlaps with that of Man II in the Golgi. Detection was with
Texas red–conjugated donkey anti–mouse IgG and FITC-conjugated donkey anti–rabbit IgG. (D) Codistribution of IP3R with both
ER and Golgi. NRK cells coimmunostained as above with anti-CALNUC IgG and mAb anti–IP3R-1 (18A10). IP3R-1 has an ER-type
distribution and also overlaps with CALNUC in the Golgi region. Analysis was carried out on whole cells. (E) Similar preparation of in-
duced EcR-CHO-CALNUC cells analyzed by confocal microscopy, showing overlap of staining for IP3R and CALNUC. Bars, 10 mm.The Journal of Cell Biology, Volume 145, 1999 286
found throughout the cytoplasm and concentrated in the
Golgi region (Fig. 3 D) which is compatible with both an
ER and Golgi localization. Confocal analysis (Fig. 3 E)
showed that the distribution of IP3R-1 overlaps with that
of CALNUC in the juxtanuclear region, suggesting that
IP3R-1 and CALNUC colocalize on Golgi membranes. As
mentioned by Pinton and co-workers (1998), it was not
possible to carry out reproducible immunogold localiza-
tion by immunoelectron microscopy with the antibody
available.
Discussion
The Golgi complex has been recently identified as a Ca21-
enriched compartment whose total Ca21 concentration is
.0.1 mM (Chandra et al., 1991; Pezzati et al., 1997; Pinton
et al., 1998), but the question of how Ca21 is sequestered
in the Golgi has remained unanswered. Previously we
showed that CALNUC is the major Ca21-binding protein
in Golgi fractions from rat liver detected by 45Ca21 overlay
(Lin et al., 1998). In this study we provide evidence that
CALNUC binds Ca21 in the Golgi in vivo, because over-
expression of CALNUC in the Golgi led to a two- to
threefold increase in Ca21 storage based on Ca21 equilib-
rium loading. This suggests that CALNUC is directly in-
volved in maintenance of Ca21 storage and thereby in
Ca21 homeostasis in the Golgi. Equilibrium dialysis dem-
onstrated the existence of only a single high affinity (Kd 5
6.6 mM)/low capacity (z1 mol Ca21/mol protein) binding
site on recombinant CALNUC. CALNUC’s low Ca21-
binding capacity in the Golgi might be compensated for by
its abundance (3.8 mg/mg Golgi protein).
The demonstration of a single, high affinity Ca21-bind-
ing site is in keeping with the fact that CALNUC possesses
two EF-hand motifs but only one, EF-1, has the structure
expected for high affinity calcium binding. EF-2 has an
Arg (R) instead of a Gly (G) at residue 6 of the EF-hand
loop region. Arg is supposed to disrupt the EF-hand motif
and abolish its Ca21-binding capacity (Branden and
Tooze, 1991). CALNUC’s EF-1 has the highest homology
to the COOH-terminal EF-4 of CaM which constitutes the
high affinity Ca21-binding site of CaM (Crouch and Klee,
1980). Moreover, the Ca21-binding capability of CAL-
Figure 5. Overexpression of CALNUC increases 45Ca21 uptake.
(A) Nontransfected HeLa cells (N.T.), or those stably transfected
with GFP alone, or transiently expressing CALNUC-GFP or
CALNUC-GFP deletion mutants were incubated with 2 mCi/ml
45Ca21 for 48 h to reach 45Ca21 equilibrium. 45Ca21 uptake by cells
overexpressing CALNUC-GFP was 2.5-fold (2,500 vs. 1,000
cpm) greater than that found in nontransfected cells or those ex-
pressing GFP alone. Truncated CALNUC in which both EF-1
[CN(DEF-1)-GFP] or EF-1 and EF-2 [CN(DEF-1, 2)-GFP] were
deleted completely lost Ca21-binding capability. (B) EcR-CHO
cells stably transfected with CALNUC cDNA (EcR-CHO-CAL-
NUC) were loaded with 45Ca21 as in A. 45Ca21 uptake in induced
cells (10 mM muristerone A) was threefold that found in nonin-
duced cells (7,400 vs. 2,500 cpm). Results (mean 6 SD) represent
the average of values obtained in three separate experiments per-
formed in duplicate.
Figure 6. Most of the 45Ca21 taken up by CALNUC in the Golgi
is released by the SERCA inhibitor Tg. Cells were incubated with
45Ca21 for 48 h as in Fig. 5 and sequentially treated with 0.1 mM Tg,
2 mM ionomycin, and 2 mM monensin. 45Ca21 release into the
medium was measured after each treatment. (A) z73%, z20%,
and 7% of the 45Ca21 was released from HeLa cells transiently
overexpressing CALNUC-GFP after Tg, ionomycin, and mo-
nensin treatments, respectively. Nontransfected HeLa cells (N.T.)
or those stably expressing GFP alone did not release as much
45Ca21 as HeLa cells overexpressing CALNUC-GFP. (B) Similar
results (70%, 25%, and 5%) for Ca21 release were obtained for
induced (5 mm ponasterone A for 24 h) EcR-CHO-CALNUC
cells following sequential treatment as above. Induced cells re-
lease twice as much 45Ca21 as noninduced cells. Results (mean 6
SD) represent the average of values obtained in three separate
experiments performed in duplicate.Lin et al. CALNUC Binds Ca21 in the Golgi 287
NUC EF-1 was demonstrated previously by 45Ca21 overlay
on truncated CALNUC. When EF-2 was deleted, Ca21
binding was maintained, but when both EF-1 and EF-2
were deleted, Ca21-binding capability was lost (Miura et
al., 1994). In this study, we further demonstrated that trun-
cated CALNUC with either the EF-1 a helix (Asp227–
Leu239) or both EF-1 and EF-2 domains (Asp227–Phe291)
deleted lost Ca21-binding capability completely. The ma-
jority of each of the CALNUC mutant proteins was still
targeted to the Golgi region as monitored via the GFP tag.
Collectively, these data suggest that EF-1 may constitute
the sole high affinity Ca21-binding site on CALNUC.
Characterization of the Ca21 pool in HeLa and CHO
cells overexpressing CALNUC provides several important
new pieces of information. 45Ca21 sequestered in the Golgi
in cells overexpressing CALNUC was largely released by
Tg, an irreversible inhibitor of the SERCA Ca21 pump,
providing in vivo evidence for the existence of SERCAs
on Golgi membranes. SERCAs were also assumed to be
localized on Golgi membranes because it was shown previ-
ously that the p-type, Tg-sensitive SERCA Ca21 pump was
essential for Ca21 uptake into isolated Golgi fractions in
vitro (Taylor et al., 1997). Our results also suggest that the
increase in 45Ca21 uptake in cells overexpressing CAL-
NUC is not likely to be due to the presence of CALNUC
in the cytosol or another recently reported Tg- and IP3-insen-
sitive Ca21 pool (Pizzo et al., 1997) since the majority of
the Ca21 was released only after SERCA was inhibited.
Our finding that only a small amount of the Ca21 re-
maining after Tg treatment was released by subsequent
Figure 7. The Golgi Ca21 pool is sensitive to stimulation with
ATP. (A) Induced (2.5 mM ponasterone A for 24 h) or nonin-
duced EcR-CHO-CALNUC cells were loaded with 1 mM Fura-2
AM for 1 h, followed by challenge with 100 mM ATP. Released
Ca21 was monitored by Ca21 imaging. More Ca21 was released
after ATP stimulation from cells overexpressing CALNUC than
from noninduced cells. Results represent the average of values
from 14 induced cells and 15 noninduced cells. Reproducible re-
sults were obtained from experiments repeated twice. (B) Nonin-
duced or induced EcR-CHO-CALNUC cells were loaded with
45Ca21 (2 mCi/ml) for 48 h to reach 45Ca21 equilibrium. Cells were
washed and resuspended in KRH buffer supplemented with 3 mM
EGTA, followed by stimulation with 100 mM ATP for 5 min at
room temperature. Aliquots of 106 cells were subsequently re-
moved, the cells were sedimented, and 45Ca21 in supernatants
and pellets was assessed. Compared with noninduced cells, there
was a twofold increase in the 45Ca21 released in cells overexpress-
ing CALNUC. Results (mean 6 SD) represent the average of
values obtained in three separate experiments performed in du-
plicate.
Figure 8. Ca21 sequestered by CALNUC in the Golgi was re-
leased directly by IP3 treatment of permeabilized cells. (A)
45Ca21 uptake. Noninduced or induced EcR-CHO-CALNUC
cells (106 cells/well) were permeabilized with 50 mg/ml saponin
for 4 min, followed by loading with 45Ca21 (10 mCi/ml) for the
times indicated. Stored 45Ca21 was extracted with 1 ml 0.1 N HCl
for 30 min, and 0.5-ml aliquots were counted. Induced cells took
up twice as much 45Ca21 as noninduced cells. 45Ca21 uptake
reached equilibrium at z45 min after loading. (B) 45Ca21 release.
Induced or noninduced EcR-CHO-CALNUC cells (106 cells/
well) were permeabilized and loaded with 10 mCi/ml of 45Ca21 for
45 min to reach equilibrium and IP3 (10 mM) was added. Aliquots
(10) were collected at 2-min intervals. Stored 45Ca21 could be di-
rectly released by IP3. Twice as much 45Ca21 was released from
induced as noninduced cells. Results (mean 6 SD) represent the
average of values obtained in three separate experiments per-
formed in duplicate.The Journal of Cell Biology, Volume 145, 1999 288
ionomycin treatment might be due to incomplete deple-
tion of Ca21 from the Golgi by Tg, since the existence of a
Tg-insensitive/ionomycin-sensitive–plasma membrane cal-
cium ATPase Ca21 pump on Golgi membranes has also
been reported recently (Taylor et al., 1997). The fact that
monensin treatment which depletes Ca21 from acidic com-
partments (secretory vesicles, granules, trans-Golgi net-
work) (Fasolato et al., 1991) did not release a significant
amount of Ca21 demonstrates that Ca21 was not seques-
tered in an acidic compartment. Thus, our current results
from in vivo studies suggest that the Ca21-binding protein
CALNUC together with SERCA Ca21 pumps are respon-
sible for the maintenance of the Golgi Ca21 storage pool.
We also investigated the agonist sensitivity of the Golgi
Ca21 pool. It was shown recently that the Golgi Ca21 store
is sensitive to histamine, an agonist known to be coupled
to IP3 generation (Pinton et al., 1998), suggesting that
there may be IP3R on Golgi membranes. Here we used ex-
tracellular ATP, another agonist known to generate IP3 af-
ter binding to plasma membrane nucleotide receptors
(P2y-purinoceptors) (O’Connor, 1992), to investigate the sen-
sitivity of the Golgi Ca21 store to IP3. ATP challenge is
coupled to IP3 production via activation of PLC (Brown et
al., 1991), and binding of IP3 to IP3R on the surface of
Ca21 pool releases intracellular Ca21 (Iredale and Hill,
1993). When ATP was added to induced EcR-CHO-CAL-
NUC cells, there was a rapid release of sequestered Ca21
revealed by both Ca21 imaging and 45Ca21 which far ex-
ceeded that released from noninduced cells. Moreover, IP3
directly triggered 45Ca21 mobilization from the Golgi in
permeabilized EcR-CHO-CALNUC cells. Thus, our bio-
chemical results and those of Pinton et al. (1998) using his-
tamine as agonist suggest that the Golgi apparatus bears
IP3R. The assumption that IP3R are expressed on the
Golgi is supported by our immunofluorescence obser-
vations suggesting a dual localization of IP3R-1 on both
ER and Golgi membranes. CHO cells were found pre-
viously to express ample IP3R-1 by immunoprecipitation
(Monkawa et al., 1995) using mAb 18A10 (Furuichi et al.,
1989) which specifically recognizes the COOH terminus of
IP3R-1.
A major controversy in the physiology of intracellular
Ca21 stores concerns the mechanism by which their deple-
tion triggers influx of Ca21 through the plasma membrane.
In vertebrate cells, it has been assumed generally that the
relevant store is the ER (Randriamampita and Tsien,
1993; Parekh and Penner, 1997). However, because both
ER and Golgi accumulate Ca21 via SERCAs and release
Ca21 via IP3 receptors, both should undergo depletion
roughly in parallel, so one cannot yet exclude a role for the
Golgi in controlling plasma membrane Ca21 influx. In
yeast, store-operated Ca21 influx appears to be controlled
mainly at the Golgi, because genetic deletion of the Golgi
Ca21 pump encoded by PMR1 increases the influx of ex-
tracellular Ca21 (Halachmi and Eilam, 1996). Therefore,
we tried to distinguish between ER and Golgi contribu-
tions by testing whether overexpression of CALNUC in
Xenopus oocytes affected the store-operated Ca21 current,
Isoc (Yao and Tsien, 1997). If the Golgi were important,
increasing the quantity of Ca21 buffer in its lumen should
diminish or delay Isoc (Mery et al., 1996; Fasolato et al.,
1998). Overexpression of CALNUC (via microinjection of
its mRNA) increased the 45Ca21 content of oocytes analo-
gously with Fig. 5 and appeared by fluorescence micros-
copy to be colocalized with the Golgi marker galactosyl-
transferase fused to GFP (Llopis et al., 1998). However,
CALNUC overexpression did not significantly affect Isoc,
either partially activated by the membrane-permeant Ca21
buffer TPEN (Arslan et al., 1985; Hofer et al., 1998) or
maximally activated by the ionophore ionomycin. This
negative result might seem to argue against a major role
for the Golgi in controlling Ca21 influx into oocytes, but a
firm conclusion would require additional controls such as
immunoelectron microscopic localization of CALNUC
and evidence that comparable increases in ER buffering
do affect Isoc.
Previously, we demonstrated significant homology be-
tween CALNUC and CRT and two conserved motifs,
AY(I/A)EE and QRLX(Q/E)E(I/E)E, located in the
C-domain of CRT (aa337–341 and 365–372) (Lin et al., 1998).
However, the homologous regions do not involve Ca21-
binding domains. CRT lacks EF-hand motifs but possesses
a high affinity/low capacity and a low affinity (Kd 5 2 mM)/
high capacity (21 mmol Ca21/mmol protein) Ca21-binding
site (Baksh and Michalak, 1991) constituted by clusters of
z35 Asp (D)/Glu (E) located in CRT’s C-domain. In the
future it will be of interest to examine whether CALNUC
can function like CRT, its ER-resident counterpart (Lin et
al., 1998), to maintain a high Ca21 concentration required
for Golgi functions, e.g., sorting, lectin binding, budding,
and concentration of cargo into regulated secretory gran-
ules.
In summary, this study demonstrates that CALNUC, an
abundant Golgi resident protein and the major Golgi
Ca21-binding protein, together with SERCA Ca21 pumps
and IP3R are involved in the maintenance of the Ca21 stor-
age pool in the Golgi. Further investigation of several re-
maining intriguing questions including whether the bind-
ing of Ca21 to CALNUC regulates membrane traffic or
posttranslational processing events in the Golgi, should
shed light on the biological functions of CALNUC and on
the Golgi Ca21 pool.
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